Stéphane Debono
Gründer bei HalioDxinvest SAS
Ursprung des Netzwerks ersten Grades von Stéphane Debono
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Miscellaneous Commercial Services | 15 | |
Pharmaxon SAS
 Pharmaxon SAS Pharmaceuticals: MajorHealth Technology Despite recent advances in diagnostics, imaging, medical devices and surgical procedures, there has been limited progress in pharmacological treatments for a number of neurological and neuro-oncological pathologies. For pathologies like central and peripheral nervous system injuries, degenerative diseases and tumours of the nervous system, the unmet medical needs are countless and there is growing expectation from the medical community, the patients and their relatives to benefit from clinically proven solutions in the future that will save and/or improve the lives of many. The limited efficacy of approved therapies for some of these pathologies and the orphan nature of others has prompted the urgent need for new researches and therapeutic strategies. At Pharmaxon, as the pioneers of a novel pharmacological approach based on cell mobility modulation, the firm is developing the future 'control keys' for improving the nervous system's endogenous regeneration, modulating neuronal networks plasticity, and inhibiting the processes which underlie tumour cell proliferation and migration. This is obtained by modulating the activity of specific adhesion molecules implicated in cell migration, cell adhesion and cell growth. Based on such a targeted strategy, Pharmaxon is opening up new avenues for the medical management of some serious, poorly-treated, neurology and neuro-oncology pathologies. To date, this has led to three R&D programs which have reached proof-of-principle, confirming the therapeutic potential of this innovative approach, in clinic stage by 2008.
7
| Extinct | Pharmaceuticals: Major | 7 |
HalioDxinvest SAS
 HalioDxinvest SAS BiotechnologyHealth Technology HalioDxinvest SAS develops and researches biotechnology products. The company was incorporated on October 17, 2014 and is headquartered in Marseille, France.
2
| Subsidiary | Biotechnology | 2 |
Ipsogen, Inc.
 Ipsogen, Inc. Medical/Nursing ServicesHealth Services Part of QIAGEN NV, Ipsogen, Inc. is a company that develops and markets molecular diagnostic tests for leukemia and breast cancer. The company is based in Stamford, CT. The company was founded by Vincent Fert.
1
| Subsidiary | Medical/Nursing Services | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Stéphane Debono
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Qiagen Finance (Luxembourg) SA | Finance/Rental/Leasing | Director/Board Member Director/Board Member Director/Board Member | |
| QIAGEN Euro Finance (Luxembourg) SA | Finance/Rental/Leasing | Director/Board Member Director/Board Member Director/Board Member | |
QIAGEN Aarhus A/S
 QIAGEN Aarhus A/S Packaged SoftwareTechnology Services QIAGEN Aarhus A/S develops and markets software and hardware solutions and consultancy services within bioinformatics. Its products include workbench, server solutions, database, and modules. The company was founded by Thomas Knudsen and Bjarne Knudsen in 2004 and is headquartered in Aarhus, Denmark. | Packaged Software | Chairman Director/Board Member Director/Board Member | |
| QIAGEN N.V. | Medical Specialties | Chief Executive Officer Director of Finance/CFO General Counsel | |
Qiagen AG
 Qiagen AG Medical SpecialtiesHealth Technology Qiagen AG manufactures biological products for purification, transfection, and amplification of nucleic acid and proteins. The company was founded on September 15, 1994 and is headquartered in Basel, Switzerland. | Medical Specialties | Director/Board Member Director/Board Member Chairman | |
| Qiagen US Finance Holding (Luxembourg) SARL | Director/Board Member Director/Board Member Director/Board Member | ||
| QIAGEN Australia Holding Pty Ltd. | Director/Board Member Director/Board Member | ||
| Qiagen Servicios Mexico S de RL de CV | Director/Board Member Director/Board Member | ||
| QIAGEN Mexico S. de R.L. de C.V. | Director/Board Member Director/Board Member | ||
| Digene Europe, Inc. | Director/Board Member Director/Board Member | ||
LDN Labor Diagnostika Nord GmbH & Co. KG
 LDN Labor Diagnostika Nord GmbH & Co. KG Pharmaceuticals: OtherHealth Technology LDN Labor Diagnostika Nord GmbH & Co. KG is a German medium-sized company that specializes in the development, production, and marketing of immunoassays for medical laboratories, food analysis, and biomedical research. LDN provides over 200 products in more than 80 countries, serving customers from clinical labs, research facilities, pharmaceutical companies, and the food industry. All of LDN's products are manufactured at its headquarters in Nordhorn, DE. The private company was founded in 1996 and has grown to become a leading player in the market for immunoassays for biogenic amines, with over 35 employees. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
QIAGEN Gaithersburg, Inc.
 QIAGEN Gaithersburg, Inc. Medical SpecialtiesHealth Technology Part of QIAGEN NV, QIAGEN Gaithersburg, Inc. is a company that manufactures and supplies diagnostic devices. The company is based in Gaithersburg, MD. | Medical Specialties | Director/Board Member Director/Board Member | |
| QIAGEN Shenzen Co. Ltd. | Director/Board Member Director/Board Member | ||
QIAGEN Canada, Inc.
 QIAGEN Canada, Inc. Chemicals: SpecialtyProcess Industries Part of Calibre Scientific, Inc., QIAGEN Canada, Inc. is a Canadian company that develops crystallization preparation tools and solutions and related screening technology. The company is based in Toronto, Canada. QIAGEN Canada was acquired by Calibre Scientific, Inc. from QIAGEN NV on January 08, 2020. | Chemicals: Specialty | Director/Board Member Director/Board Member | |
Tian Gen Biotech (Beijing) Co. Ltd
 Tian Gen Biotech (Beijing) Co. Ltd Medical DistributorsDistribution Services Part of QIAGEN NV, Tian Gen Biotech (Beijing) Co. Ltd is a Chinese company that engages in the development of nucleic acid preparation products. The company is based in Beijing, China. Tian Gen Biotech (Beijing) Co. was acquired by QIAGEN NV on July 12, 2005 for $0.24 million. | Medical Distributors | Director/Board Member Director/Board Member | |
Qiagen Hamburg GmbH
 Qiagen Hamburg GmbH Medical/Nursing ServicesHealth Services Part of QIAGEN NV, QIAGEN Hamburg GmbH is a German company that delivers sample to insights solutions, enabling customers to unlock insights from the building blocks of life - DNA, RNA, and proteins. The company is based in Hilden, Germany. The CEOs are Peer Michael Schatz and Roland Sackers. The company was founded in 2013. | Medical/Nursing Services | Chief Executive Officer Chief Executive Officer | |
Qiagen Benelux BV
 Qiagen Benelux BV BiotechnologyHealth Technology Part of QIAGEN NV, QIAGEN Benelux BV provides biotechnology services. The company is based in Venlo, Netherlands. QIAGEN Benelux was founded in 1984. | Biotechnology | Chairman Chairman | |
| QE-Diagnostiksysteme GmbH | Director/Board Member Director/Board Member | ||
| QIAGEN China (Shanghai) Co. Ltd. | Director/Board Member Director/Board Member | ||
| QIAGEN Pte Ltd. | Director/Board Member Director/Board Member | ||
| QIAGEN Korea Ltd. | Director/Board Member Director/Board Member | ||
| QIAGEN Singapore Pte Ltd. | Director/Board Member Director/Board Member | ||
| Corbett Research UK Ltd. | Director/Board Member Director/Board Member | ||
| Cellestis (R&D) Pty Ltd. | Director/Board Member Director/Board Member | ||
QIAGEN Sciences LLC
 QIAGEN Sciences LLC Medical SpecialtiesHealth Technology Part of QIAGEN NV, QIAGEN Sciences LLC is a company that manufactures and distributes sample and assay technology products for preanalytical sample preparations. The company is based in Germantown, MD. | Medical Specialties | Director/Board Member Director/Board Member | |
| Qiagen Redwood City, Inc. | Director/Board Member Director/Board Member | ||
| Qiagen Business Services Sp zoo | Director/Board Member Director/Board Member | ||
| N-Dia, Inc. | Director/Board Member Director/Board Member | ||
Amnisure International LLC
 Amnisure International LLC Electronic Equipment/InstrumentsElectronic Technology Amnisure International LLC manufactures and distributes medical assays in determining the presence of a rupture of fetal membranes in pregnant women. The firm’s technology includes Amnisure ROM test, PAMG-1 Protein, Lateral Flow, Alpha Fetoprotein and Biomarker Testing for PROM and Non-Invasive PROM & pPROM testing. The company was founded in 2005 and is headquartered in Boston, MA. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
Intelligent Bio-Systems, Inc.
 Intelligent Bio-Systems, Inc. Medical SpecialtiesHealth Technology Intelligent Bio-Systems is developing a next generation DNA sequencing system that can simultaneously increase the speed and reduce the cost of producing sequence data by a factor of 100 to 1,000. It uses a proprietary chemistry, high-density chip and fluorescent instrument system to accurately decode the sequence of DNA fragments. The technology has the potential to dramatically change the way research is performed and healthcare is delivered. | Medical Specialties | Director/Board Member Director/Board Member | |
| QIAGEN India Pvt Ltd. | Director/Board Member Director/Board Member | ||
| Qiagen Taiwan Co. Ltd. | Director/Board Member Director/Board Member | ||
| Cellestis International | Director/Board Member Director/Board Member | ||
| Qiagen Biosciences GmbH | Director/Board Member Director/Board Member | ||
Cellestis Pty Ltd.
 Cellestis Pty Ltd. BiotechnologyHealth Technology Cellestis Ltd. develops, manufactures and markets medical diagnostic products. It develops and markets QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune responses of T cell lymphocytes using whole blood samples. Its product portfolio includes QuantiFERON-CMI kit, an in vitro laboratory test for the measurement of cell mediated immune responses in humans using whole blood, QuantiFERON-TB Gold, an in vitro diagnostic test for the detection of mycobacterium tuberculosis infection. The company was founded in 2000 and is headquartered in Chadstone, Australia. | Biotechnology | Director/Board Member Director/Board Member | |
Indical Bioscience GmbH
 Indical Bioscience GmbH Miscellaneous Commercial ServicesCommercial Services INDICAL BIOSCIENCE GmbH provides solutions for molecular diagnostics for vet-specific applications. It offers diagnostics for better animal and human health. The company was founded in 1996 and is headquartered in Leipzig, Germany. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Qiagen Hong Kong Pte Ltd.
 Qiagen Hong Kong Pte Ltd. Medical SpecialtiesHealth Technology Part of QIAGEN NV, Qiagen Hong Kong Pte Ltd. is a company that manufactures and wholesales laboratory equipment. The company is based in Hong Kong, Hong Kong. | Medical Specialties | Director/Board Member Director/Board Member | |
| ATQ Biyoteknoloji Iç ve Dis Ticaret Ltd. | Director/Board Member Director/Board Member | ||
QIAGEN Lake Constance GmbH
 QIAGEN Lake Constance GmbH Electronic ComponentsElectronic Technology QIAGEN Lake Constance GmbH develops and produces optical measurement devices for medical, environmental and industrial applications. The company was founded by Thomas Wiest, Klaus Haberstroh, Roland Sackers, Peer Michael Schatz, and Jörg Schickedanz in 1997 and is headquartered in Stockach, Germany. | Electronic Components | Chief Executive Officer Chief Executive Officer | |
DxS Ltd.
 DxS Ltd. Medical SpecialtiesHealth Technology DxS Ltd. is a personalized medicine company which engages in the development and manufacture of companion diagnostic products. Its products make use of molecular diagnostics to aid doctors and drug companies in selecting therapies for patients. It offers its products, technology, and services to the healthcare industry to enable the delivery of safe and effective medicines. The company was founded by David Whitcombe in 2001 is headquartered in Manchester, the United Kingdom. | Medical Specialties | Director/Board Member Director/Board Member | |
QIAGEN Manchester Ltd.
 QIAGEN Manchester Ltd. Pharmaceuticals: MajorHealth Technology Part of QIAGEN NV, QIAGEN Manchester Ltd. is a pharmaceutical manufacturing company. The company is based in Manchester, UK. QIAGEN Manchester was founded in 2001. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Corbett Robotics Pty Ltd. | Director/Board Member Director/Board Member |
Statistik
International
| Vereinigte Staaten | 11 |
| Australien | 9 |
| Deutschland | 7 |
| Luxemburg | 4 |
| Vereinigtes Königreich | 4 |
Sektoral
| Health Technology | 15 |
| Health Services | 4 |
| Finance | 3 |
| Commercial Services | 3 |
| Electronic Technology | 3 |
Operativ
| Director/Board Member | 212 |
| Chairman | 121 |
| Chief Executive Officer | 34 |
| Corporate Officer/Principal | 28 |
| Founder | 21 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Peer Schatz | 83 |
| Roland Sackers | 78 |
| Kevin Rakin | 35 |
| Gilles Alberici | 18 |
| Dean Marc Slagel | 18 |
| Philipp Sixt Lothar von Hugo | 14 |
| Jérôme Féraud | 12 |
| Guillaume Connan | 10 |
| Vincent Fert | 10 |
| Pascale Boissel | 8 |
| Glenn Stanley | 6 |
| Fabienne Hermitte | 6 |
| Hélène Peyro-Saint-Paul | 5 |
| Corinne Danan | 4 |
| Pascal Deschaseaux | 4 |
- Börse
- Insiders
- Stéphane Debono
- Unternehmensverbindungen